CM Management LLC Raises Holdings in Assertio Holdings, Inc. (NASDAQ:ASRT)

CM Management LLC boosted its stake in Assertio Holdings, Inc. (NASDAQ:ASRT) by 23.1% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 400,000 shares of the company’s stock after buying an additional 75,000 shares during the quarter. CM Management LLC owned approximately 0.42% of Assertio worth $348,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Captrust Financial Advisors acquired a new position in shares of Assertio in the third quarter worth $26,000. Sonora Investment Management Group LLC acquired a new position in Assertio in the 4th quarter valued at about $39,000. Thurston Springer Miller Herd & Titak Inc. lifted its holdings in Assertio by 33.7% in the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 67,500 shares of the company’s stock valued at $59,000 after purchasing an additional 17,000 shares in the last quarter. GSA Capital Partners LLP acquired a new stake in shares of Assertio during the 3rd quarter worth about $177,000. Finally, Palumbo Wealth Management LLC grew its holdings in shares of Assertio by 10.6% during the fourth quarter. Palumbo Wealth Management LLC now owns 205,598 shares of the company’s stock worth $179,000 after buying an additional 19,637 shares in the last quarter. Hedge funds and other institutional investors own 48.96% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the stock. HC Wainwright restated a “buy” rating and set a $4.00 target price on shares of Assertio in a research report on Monday, December 16th. StockNews.com upgraded Assertio from a “hold” rating to a “buy” rating in a report on Wednesday, November 13th.

Assertio Price Performance

Assertio stock opened at $0.78 on Friday. Assertio Holdings, Inc. has a 1 year low of $0.73 and a 1 year high of $1.80. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.57 and a current ratio of 2.01. The firm has a 50 day moving average price of $0.82 and a 200 day moving average price of $0.98. The company has a market cap of $74.65 million, a price-to-earnings ratio of -1.07, a PEG ratio of 3.25 and a beta of 0.81.

Assertio Profile

Assertio Holdings, Inc, a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.